Fantastic reading, as expected.
I have confidence in their approach below - which history show is exactly what they did for PhII for Trof - and we all know how that turned out
"In order to accelerate the overall development plan, in parallel with conducting the Phase 2 trials Neuren is executing the additional development work
required to be ready for Phase 3 development. This includes non-clinical toxicity studies to support longer clinical trials and commercial use of the product as well as optimisation of the drug product and drug substance manufacturing arrangements."
- Forums
- ASX - By Stock
- NEU
- Ann: Q4 2023 quarterly activity report
Ann: Q4 2023 quarterly activity report, page-2
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.34 |
Change
0.320(1.68%) |
Mkt cap ! $2.469B |
Open | High | Low | Value | Volume |
$19.20 | $19.41 | $18.55 | $13.89M | 728.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 624 | $19.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.35 | 6719 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 624 | 19.340 |
1 | 236 | 19.310 |
1 | 2044 | 19.300 |
1 | 5375 | 19.230 |
1 | 1150 | 19.210 |
Price($) | Vol. | No. |
---|---|---|
19.370 | 17246 | 2 |
19.380 | 1000 | 1 |
19.420 | 2027 | 1 |
19.480 | 2027 | 1 |
19.500 | 3000 | 1 |
Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
$19.40 |
  |
Change
0.320 ( 1.70 %) |
|||
Open | High | Low | Volume | ||
$19.12 | $19.40 | $18.55 | 139309 | ||
Last updated 15.59pm 05/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online